Integrin alpha 2 beta 1 Antibody [DyLight 594] - (Research Grade vatelizumab Biosimilar)
Novus Biologicals, part of Bio-Techne | Catalog # NBP3-28512DL594
Key Product Details
Species Reactivity
Applications
Label
Antibody Source
Concentration
Product Specifications
Immunogen
Clonality
Host
Isotype
Description
Also known as 'vatelizumab'.
IgG4SP is human IgG4 with S228P mutation.
Applications
ELISA
Flow Cytometry
Functional
Formulation, Preparation, and Storage
Purification
Formulation
Preservative
Concentration
Shipping
Stability & Storage
Background: Integrin alpha 2 beta 1
Integrin alpha 2 beta 1 (VLA-2) is one of twelve Integrin family adhesion receptors that share the beta 1 subunit. It is one of six very late antigens expressed on activated T cells. Divalent cations and intracellular (inside-out) signaling convert it to its most active, extended, and open conformation. alpha 2 beta 1 binds to Collagen types I, II, and III, Laminin, Decorin, E-Cadherin, and Collectin molecules such as C1q. Platelet a2b1, also called GPIa, cooperates with GPVI to coordinate platelet collagen binding and activation. Adhesion is enhanced by crosstalk with Syndecan-1 or HGF R/c-Met and antagonized by crosstalk with Integrin a1b1. a2b1 is additionally expressed on select hematopoietic and non-hematopoietic cells.
Alternate Names
Additional Integrin alpha 2 beta 1 Products
Product Specific Notices
DyLight (R) is a trademark of Thermo Fisher Scientific Inc. and its subsidiaries.
This product is for research use only and is not approved for use in humans or in clinical diagnosis. Primary Antibodies are guaranteed for 1 year from date of receipt.